Search

Author/Creator Long, Jianting

1. Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial. Issue 8 (August 2021)

Authors:
Yang, Yunpeng; Qu, Song; Li, Jingao; Hu, Chaosu; Xu, Mingjun; Li, Weidong; Zhou, Ting; Shen, Liangfang; Wu, Hui; Lang, Jinyi; Hu, Guangyuan; Luo, Zhanxiong; Fu, Zhichao; Qu, Shenhong; Feng, Weineng; Chen, Xiaozhong; Lin, Shaojun; Zhang, Weimin; Li, Xiaojiang; Sun, Yan
Journal:
Lancet oncology
Issue:
Volume 22:Issue 8(2021)
Page Start:
1162
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience. (1st January 2020)

Authors:
Liu, Baoxian; Huang, Guangliang; Xie, Xiaohua; Zhao, Qiang; Su, Liya; Liu, Ming; Li, Xiaoju; Long, Jianting; Kuang, Ming; Xie, Xiaoyan
Journal:
International journal of hyperthermia
Issue:
Volume 37:Number 1(2020)
Page Start:
1202
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Improvement of HBsAg Gene-Modified Dendritic Cell-Based Vaccine Efficacy by Optimizing Immunization Method or the Application of β-glucosylceramide. (February 2013)

Authors:
Long, Jianting; Zhou, Bo; Li, Heping; Dai, Qiangsheng; Zhang, Bing; Xing, Sizhong; Zeng, Zhirong; Chen, Wei; Yang, Jianyong
Journal:
Immunological investigations
Issue:
Volume 42:Number 2(2013)
Page Start:
137
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗